Clinical Trials in San Antonio

Showing 881-900 of 7,028 trials

ACTIVE_NOT_RECRUITINGPHASE2< 1 mile

A Study in Patients With Mixed Dyslipidemia

NCT06497127

A Phase 2 in Patients With Mixed Dyslipidemia

Mixed Dyslipidemia

Shanghai Argo Biopharmaceutical Co., Ltd.145 participantsStarted Feb 2024

Daphne, Alabama, United States • Mobile, Alabama, United States • Boca Raton, Florida, United States +11 more locations

ACTIVE_NOT_RECRUITINGPHASE1< 1 mile

Study of ENV-294 in Healthy Adults and in Adults With Moderate-to-Severe Atopic Dermatitis

NCT07336940

The goal of this clinical trial is to learn about the safety and tolerability of ENV-294 in adults with moderate to severe atopic dermatitis. It may also learn about the changes ENV-294 may have on the severity of atopic dermatitis symptoms. The main questions it will answer are: * Is ENV-294 safe and well tolerated in adults with moderate to severe atopic dermatitis? * Is there an impact on the severity of atopic dermatitis symptoms when participants take ENV-294? Researchers will review the atopic dermatitis present at the beginning of the study against the atopic dermatitis present at the end of the study. Participants will: * Take drug ENV-294 once every day for 28 days * Visit the clinic weekly for 4 weeks for checkups and tests * Keep a diary of their symptoms and when they took their study drug ENV-294

Atopic Dermatitis (AD)

Enveda Therapeutics16 participantsStarted Sep 2025

Fremont, California, United States • Louisville, Kentucky, United States • College Station, Texas, United States +2 more locations

A Study in Patients With Mixed Dyslipidemia

Study of ENV-294 in Healthy Adults and in Adults With Moderate-to-Severe Atopic Dermatitis

Find Trials by Condition in San Antonio

Field Shield Wound Dressing Study

Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer

Promotion of Weight Management

A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis

Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers

A Single Arm Study Evaluating the Efficacy, Safety and Tolerability of Ofatumumab in Patients With Relapsing Multiple Sclerosis

IC-8 Apthera IOL New Enrollment Post Approval Study

A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)

FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3

ALRN-6924 in Patients With Advanced Solid Tumors or Lymphomas

Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure

A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)

Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma

A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)

An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients.

Single Arm, Open Label Trial With Iptacopan Treatment for 24 Weeks, in Patients on Stable Regimen of Anti-C5 Who Switch to Iptacopan.

Liver Cirrhosis Network Cohort Study

Nivolumab + Chemoradiation in Stage II-IVB Nasopharyngeal Carcinoma (NPC)